Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase

Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase

US Patent 11357832 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CNS delivery of therapeutic agents2025
Composition and methods for treatment of ornithine transcarbamylase deficiency2025
Composition and methods for treatment of ornithine transcarbamylase deficiency2025
Aptamer therapeutics useful in the treatment of complement-related disorders2024
CNS delivery of therapeutic agents2022
Composition and methods for treatment of ornithine transcarbamylase deficiency2021
Composition and methods for treatment of ornithine transcarbamylase deficiency2021
Aptamer therapeutics useful in the treatment of complement-related disorders2021
Determination of glycosaminoglycan levels by mass spectrometry2020
Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of 2020
Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of 2020
Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of 2020